QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
Metoclopramide (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 50 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiemetic |
| Classification: | Drug Assays |
Metoprolol (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 80 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Metoprolol (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2 – 500 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Midazolam
1’-Hydroxymidazolam (Matrix: Human Plasma)
1’-Hydroxymidazolam (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 to 100 ng/mL 0.1 to 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | K2 EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Sedative |
| Classification: | Drug Assays |
Midazolam1-OH Midazolam (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 100 ng/mL 0.1 – 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Lithium Heparin |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Sedative |
| Classification: | Drug Assays |
Midazolam1-OH-midazolam (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.100 – 100 ng/mL |
| Sample Volume: | 0.100 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Sedative |
| Classification: | Drug Assays |
Midazolam1-OH-Midazolam (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | 0.100 – 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Sedative |
| Classification: | Drug Assays |
Midazolam1-OH-Midazolam (Matrix: Human Dried Blood Spots)
| Matrix: | Human Dried Blood Spots |
| Assay Range: | 0.100 – 100 ng/mL |
| Sample Volume: | 0.02 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Sedative |
| Classification: | Drug Assays |
Midazolam1-OH-Midazolam4-OH-Midazolam (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Sedative |
| Classification: | Drug Assays |
Miglitol (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 30 – 3,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Anti-diabetic |
| Classification: | Drug Assays |
Mitiglinide (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 2,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Anti-diabetic |
| Classification: | Drug Assays |
Modafinil (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 20,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drug Assays |
Monomethyl Fumarate (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 15 – 6,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Multiple Sclerosis |
| Classification: | Drug Assays |
Montelukast (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2 – 800 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Allergy |
| Classification: | Drug Assays |
Montelukast (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2 – 400 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Allergy |
| Classification: | Drug Assays |
Morphine (Matrix: Mouse Plasma)
| Matrix: | Mouse Plasma |
| Assay Range: | 0.2 – 500 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Narcotic Analgesic |
| Classification: | Drug Assays |
Morphine
Morphine 3-glucuronide
Morphine 6-glucuronide (Matrix: Human Plasma)
Morphine 3-glucuronide
Morphine 6-glucuronide (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 50 ng/mL 10 – 1,000 ng/mL 1 – 100 mg/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Narcotic Analgesic |
| Classification: | Drug Assays |
Moxifloxacin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 25 – 5,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Moxifloxacin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 7,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
MT-RNR1 (1555A>G) and MT-TS1 (3243A>G) Mitochondrial DNA Genotyping (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | N.Ap. |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | Pyrosequencing |
| Site: | QPS-Delaware |
| CLIA: | |
| Therapy Area: | |
| Classification: | Genomic Biomarkers |
Mycophenolate Mofetil (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 16,000 pg/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Immunosuppressant |
| Classification: | Drug Assays |
Mycophenolate Mofetil in presence of Mycophenolic Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 20,000 pg/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Immunosuppressant |
| Classification: | Drug Assays |
Mycophenolic Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 40 µg/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Immunosuppressant |
| Classification: | Drug Assays |
Mycophenolic Acid (Matrix: Human plasma)
| Matrix: | Human plasma |
| Assay Range: | 20.0 – 5,000 ng/mL |
| Sample Volume: | 0.100 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Immunosuppressant |
| Classification: | Drug Assays |
Mycophenolic Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 5,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Immunosuppressant |
| Classification: | Drug Assays |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
